Cytogen Pharmaceuticals (India) Private Limited, a active private limited company, was established on 10 December 2003 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239DL2003PTC123455. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.60 M.
Formerly known as Cytogen Pharmacuticals (India) Private Limited. It upholds a compliant status. Its leadership includes Jayapal Garapati (Whole-Time Director), Venkatasatyasiva Ramakrishnaraju Bhupathiraju (Director), Jhansirani Nadimpalli (Director). Past directors included Kailash Nath Behl, Tarun Garg, Jayapal Garapati. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at A-8, Block-B-1, First Floor, Mohan Corporate Industrial Estate, Mathura Road, New Delhi, Delhi, 110044.
U24239DL2003PTC123455
123455
10 December 2003
₹2.50 M
₹1.60 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Cytogen Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jayapal Garapati | Whole-Time Director | 12 Nov 2020 | Current |
| Venkatasatyasiva Ramakrishnaraju Bhupathiraju | Director | 26 Oct 2020 | Current |
| Jhansirani Nadimpalli | Director | 26 Oct 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 May 2009 | Past |
| Pramod Abcsdd | Director | 01 Sep 2007 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2021 | Past |
| Pramod Abcsdd | Director | 01 Sep 2007 | Past |
| Pramod Abcsdd | Director | 26 Oct 2020 | Past |
| Pramod Abcsdd | Director | 26 Oct 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cytogen Pharmaceuticals (India) Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 16.34% decrease. The company also saw a substantial improvement in profitability, with a 102.71% increase in profit. The company's net worth Soared by an impressive increase of 148.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Cytogen Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Cytogen Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cytogen Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytogen Pharmaceuticals (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cytogen Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
The activity Cytogen Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi. was completed.
Jayapal Garapati was appointed as a Whole-time director was appointed as a Whole-time director on 12 Nov 2020 & has been associated with this company since 5 years 2 months . was recorded as a recent event.
Progress on Venkatasatyasiva Ramakrishnaraju Bhupathiraju was appointed as a Director was appointed as a Director on 26 Oct 2020 & has been associated with this company since 5 years 2 months . was documented.
The activity Jhansirani Nadimpalli was appointed as a Director was appointed as a Director on 26 Oct 2020 & has been associated with this company since 5 years 2 months . was completed.
The activity Cytogen Pharmaceuticals (India) Private Limited was registered on 10 Dec 2003 with Roc Delhi & aged 22 years 1 month as per MCA records. was completed.
The CIN of Cytogen Pharmaceuticals (India) Private Limited is U24239DL2003PTC123455.
Cytogen Pharmaceuticals (India) Private Limited is headquartered at A-8, Block-B-1, First Floor, Mohan Corporate Industrial Estate, Mathura Road, New Delhi, Delhi, 110044.
Cytogen Pharmaceuticals (India) Private Limited was incorporated on 10 December 2003.
The current directors of Cytogen Pharmaceuticals (India) Private Limited are
The primary industry of Cytogen Pharmaceuticals (India) Private Limited is Trade.
Cytogen Pharmaceuticals (India) Private Limited is unlisted.
The authorized capital of Cytogen Pharmaceuticals (India) Private Limited is ₹2.50 M, and the paid-up capital is ₹1.60 M.
The compliance status of Cytogen Pharmaceuticals (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX